The New Zealand sharemarket experienced a decline, mirroring a global sell-off, closing at 13,711.01 – down 0.78% or 108.42 points. A significant contributor to this downturn was Ryman Healthcare, which reached a 16-year low in trading. Simultaneously, oil prices surged, exceeding US$100 (NZ$171.25) per barrel. The S&P/NZX 50 Index showed a consistent downward trend throughout the trading day. This performance reflects broader international economic pressures impacting the New Zealand financial landscape. Investors reacted to these factors, leading to the overall market contraction in New Zealand. The drop in Ryman Healthcare's value particularly highlighted investor anxieties.